옵션 체인은 다양한 행사가격과 만기일에 대한 Ontrak의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Ontrak에 대한 시장 심리를 평가합니다..

Ontrak (NASDAQ:OTRK) 주식, 옵션 체인

Ontrak

Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.

Earnings

News

Penny Stocks

Pre-Market Outlook

Markets

Trading Ideas

ITCI

OTRK

수요일 오전 미국 주식 선물이 상승하면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다: Benzinga Pro의 데이터에 따르면 월스트리트는 애벗 래버러토리스(NYSE:ABT)가 개장 전에 98억 8천만 달러의 매출과 주당 95센트의 분기 수익을 보고할 것으로 예상하고 있다. 애벗 주식은 시간 외 거래에서 1% 상승한 110.30달러를 기록했다.

애벗 래버러토리스, U.S. 뱅코프 및 수요일에 주목해야 할 3가지 주식

Ontrak Inc

Morgan Stanley analyst Joseph Moore downgrades Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) from Overweight to Equal-Weight and maintains the price target from $142 to $142.

Downgrades

Price Target

Analyst Ratings

ALAB

Morgan Stanley Downgrades Astera Labs to Equal-Weight, Maintains Price Target to $142

Morgan Stanley analyst John Glass downgrades Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) from Equal-Weight to Underweight and lowers the price target from $22 to $14.

Morgan Stanley Downgrades Wendy's to Underweight, Lowers Price Target to $14

<a href="https://www.wsj.com/real-estate/commercial/the-u-s-government-has-a-landlord-and-trump-isnt-a-fan-872c469e" title="https://www.wsj.com/real-estate/commercial/the-u-s-government-has-a-landlord-and-trump-isnt-a-fan-872c469e">https://www.wsj.com/real-estate/commercial/the-u-s-government-has-a-landlord-and-trump-isnt-a-fan-872c469e</a>

iShares Trust Dow Jones US Real Estate Fund Index

The Wall Street Journal Reported The Trump Administration Is Considering Selling Two-thirds Of The Federal Government's Office Stock To The Private Sector

Morgan Stanley analyst John Glass downgrades Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) from Overweight to Equal-Weight and lowers the price target from $158 to $140.

Morgan Stanley Downgrades Yum Brands to Equal-Weight, Lowers Price Target to $140

Shares of INNOVATE Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) rose sharply in today's <a href="https://www.benzinga.com/quote/VATE">pre-market trading</a>.
INNOVATE announced the FDA approval of MediBeacon&#8217;s TGFR System For accurate kidney function testing.
INNOVATE shares jumped 19.4% to $6.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>EON Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EONR#NYSE">EONR</a>) gained 89.2% to $1.93 in pre-market trading.</li>
<li>Dogwood Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) rose 62.5% to $3.04 in pre-market trading after falling 3% on Friday.</li>
<li>Crown Electrokinetics Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) rose 43.5% to $0.1794 in pre-market trading. Crown Electrokinetics shares jumped around 57% on Friday after the company announced it entered into an exclusive partnership with Electro Scan.</li>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) gained 30.7% to $2.33 in pre-market trading. Trio Petroleum said as of Jan. 7, it has fully repaid senior secured convertible promissory notes with aggregate principal of $1.6 million.</li>
<li>Tempus AI, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 22.9% to $43.21 in pre-market trading.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) gained 22.8% to $0.9185 in pre-market trading.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) gained 22.6% to $1.63 in pre-market trading.</li>
<li>First Foundation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NYSE">FFWM</a>) gained 12.7% to $7.09 in pre-market trading. First Foundation will release its fourth quarter 2024 earnings results before the opening bell on Thursday, Jan. 30.</li>
<li>Riskified Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) gained 9.2% to $5.49 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Canoo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) fell 72.3% to $0.3736 in pre-market trading after the company announced Chapter 7 bankruptcy filing, ending operations effective immediately.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) shares fell 30.3% to $0.78 in pre-market trading after dipping 72% on Friday.</li>
<li>Treace Medical Concepts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMCI#NASDAQ">TMCI</a>) fell 29.4% to $6.14 in pre-market trading after gaining over 5% on Friday.</li>
<li>IF Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IROQ#NASDAQ">IROQ</a>) shares dipped 29.4% to $18.00 in pre-market trading after gaining 6% on Friday.</li>
<li>TechTarget, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) shares tumbled 19.5% to $14.00 in pre-market trading.</li>
<li>Elicio Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares fell 19.4% to $5.10 in pre-market trading.</li>
<li>Baird Medical Investment Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDMD#NASDAQ">BDMD</a>) fell 18.2% to $7.24 in today's pre-market trading after jumping 63% on Friday.</li>
<li>Rayonier Advanced Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NYSE">RYAM</a>) declined 17.1% to $6.24 in pre-market trading</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) fell 16.2% to $50.98 in pre-market trading after the company announced weak quarterly earnings.</li>
<li>SWK Holdings Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) dipped 14.3% to $14.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43089042/3m-netflix-and-3-stocks-to-watch-heading-into-tuesday">3M, Netflix And 3 Stocks To Watch Heading Into Tuesday</a></li>
</ul>

Movers

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Why INNOVATE Shares Are Trading Higher By Over 19%; Here Are 20 Stocks Moving Premarket

Amazon.com Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) autonomous driving unit Zoox is reportedly looking to begin offering rides to the public &#8220;quite soon.&#8221;
What Happened: Zoox co-founder Jesse Levinson <a href="https://www.cnbc.com/2025/01/17/amazon-zoox-plans-commercial-expansion.html">told</a> CNBC that the company intends to offer rides to the public and significantly grow its fleet of self-driving vehicles in 2025.
Zoox is currently testing its vehicles on the roads of San Francisco, Las Vegas, and Foster City, California. 
According to CNBC, the company will first launch commercial services in Las Vegas, followed by San Francisco. The company will launch an &#8220;early rider program&#8221; in Las Vegas in the coming months and open rides to the public later this year, the report said.
Zoox is also eyeing expansion to Miami and Austin, Levinson told CNBC, without detailing a timeline. 
"I don't want to imply that it'll be a commercially meaningful business this year … but it's going to be useful in terms of customers will be able to get value out of it and actually use it to go places. We're excited for that," Levinson told CNBC. "We've taken a pretty conservative and steady approach to scaling and rolling out, just because of the safety-critical nature."
Why It Matters: Zoox, once operational, will be up against Alphabet&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Waymo which is already operating its robotaxis in Phoenix and Los Angeles.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is also looking to join the robotaxi business in 2025. During the company's third-quarter earnings call last year, Elon Musk said that the company expects to start a ride-hail service in Texas and California starting next year, <a href="https://www.benzinga.com/news/24/10/41484511/palo-alto-may-open-streets-to-tesla-robotaxis-but-california-regulators-will-decide-fate" target="_blank" rel="noreferrer noopener">subject to regulatory approval</a>, with Model 3 and Model Y vehicles equipped with its full self-driving (FSD) driver assistance technology.
However, the vehicles might not all operate as driverless robotaxis but with a driver as some states demand it until the company touches certain milestones in terms of miles and hours driven, the company then said. Musk, known for overestimating his company&#8217;s products, expressed confidence about the&nbsp;<a href="https://www.benzinga.com/top-stories/24/10/41279865/elon-musk-may-unveil-teslas-robotaxi-but-consumers-respond-with-ehhh-new-study-reveals-skepticism-ne" target="_blank" rel="noreferrer noopener">company operating driverless paid rides sometime in 2025</a> despite its FSD technology not achieving fully autonomous driving yet. 
Levinson in October dismissed the possibility of Tesla deploying autonomous vehicles without safety drivers in California this year,&nbsp;<a href="https://www.benzinga.com/news/24/10/41645383/elon-musk-slams-zoox-co-founder-over-fsd-criticism-your-company-would-be-dead-already-if-not-for-ama" target="_blank" rel="noreferrer noopener">alleging that the EV giant&nbsp;</a>lacks a technology that works.
Tesla is faced with a lot of regulatory hurdles that they haven&#8217;t even started trying to climb yet, Levinson&nbsp;<a href="https://www.youtube.com/watch?v=RwFzIm-M6TU" target="_blank" rel="noreferrer noopener">said</a>&nbsp;at the TechCrunch Disrupt 2024 event in San Francisco. But the fundamental problem, he said, is that Tesla doesn&#8217;t have a &#8220;technology that worked.&#8221;
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43090016/which-evs-might-lose-7500-ev-tax-credit-under-trump-administration">Here Are The EVs Which Could Lose $7,500 EV Tax Credit Under Trump Administration</a></li>
</ul>
Photo courtesy: Zoox

Tech

Media

AMZN

GOOG

GOOGL

TSLA

Amazon's Zoox Eyes Joining Leagues Of Waymo In 2025, To Offer Rides To Public 'Quite Soon'

Macro Economic Events

Econ #s

Economics

Eurozone ZEW Economic Sentiment For January 18.0 Vs. 16.9 Est.; 17.0 Prior

Germany ZEW Economic Sentiment For January 10.3 Vs. 15.2 Est.; 15.7 Prior

Morgan Stanley analyst John Glass upgrades Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>) from Equal-Weight to Overweight and raises the price target from $205 to $213.

Upgrades

TXRH

Morgan Stanley Upgrades Texas Roadhouse to Overweight, Raises Price Target to $213

Germany ZEW Current Conditions For January -90.4 Vs. -93.1 Est.; -93.1 Prior

MBWM

Mercantile Bank Corporation Says Overall Financial Standing And Commercial Loan Funding Will Allow Company To Meet Challenges Arising From Changing Operating Environments

Mercantile Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBWM#NASDAQ">MBWM</a>) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $1.14 by 7.02 percent. This is a 2.4 percent decrease over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $58.500 million which beat the analyst consensus estimate of $57.378 million by 1.96 percent. This is a 2.72 percent increase over sales of $56.949 million the same period last year.

Earnings Beats

Mercantile Bank Q4 2024 GAAP EPS $1.22 Beats $1.14 Estimate, Sales $58.500M Beat $57.378M Estimate

Net interest income was Baht 149,376 million, a slight increase of Baht 932 million or 0.63% from the previous year partly due to limited loan growth in line with the economic situation and the enhancement of credit underwriting processes to ensure quality lending. Net interest margin ratio stood at 3.64%, a slight decrease from the previous year. Non-interest income was Baht 48,570 million, an increase of Baht 4,361 million or 9.86% mainly due to increased fee income from customer's wealth management service through the offering of comprehensive financial products from the Bank and its subsidiaries, as well as partners. Additionally, there was an increase in gains from financial instruments measured at fair value through profit or loss and investment income, along with increased revenue from foreign exchange transactions which were in line with the recovery of tourism.

KPCPY

Kasikornbank Public Company Q4 Net Interest Income Baht 36,345M Down 6.5% YoY; EPS Bhat 4.43 Up 11.9% YoY

Mercantile Bank Corporation Declared Regular Quarterly Cash Dividend Of $0.37 Per Common Share, Which Is  5.7% Higher Than Cash Dividends Paid During Q1 Of 2024; Dividend Is Payable On March 19, 2025

General

Know Labs Forms New Business Unit To Cater To intellectual Property Portfolio

Editor&#8217;s Note: This story has been updated to include premarket price movements.
MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares dropped 3.43% in Tuesday premarket, falling to $382.90 as cryptocurrency markets reacted to President Donald Trump&#8216;s inauguration speech that notably <a href="https://www.benzinga.com/25/01/43086698/crypto-market-plunges-after-trumps-inaugural-speech-fails-to-mention-digital-assets">omitted any mention of digital assets</a>.
What Happened: The enterprise software company, which holds over $45 billion in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), had seen its stock surge 8.04% to $396.50 on Friday amid optimism about Trump&#8217;s anticipated crypto-friendly policies. 
The company&#8217;s executive chairman Michael Saylor attended a &#8220;Crypto Ball&#8221; last Friday where he met with Trump&#8217;s incoming cabinet members, fueling speculation about <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43078515/michael-saylor-meets-trumps-cabinet-at-crypto-ball-what-does-the-bitcoin-bulls-cryptic-post-indicate">favorable cryptocurrency regulations</a>.
However, Trump&#8217;s inaugural address focused instead on traditional assets, declaring the start of a &#8220;Golden Age of America&#8221; &#8211; a reference that prompted Bitcoin critic Peter Schiff to highlight the president&#8217;s apparent preference for gold over cryptocurrency. 
See Also: <a href="https://www.benzinga.com/25/01/43088034/bitcoin-ethereum-dogecoin-retrace-from-pre-inauguration-highs-as-trumps-address-disappoints-analyst-highlights-possibility-of-btc-consolidation-in-101k-106k-range">Bitcoin, Ethereum, Dogecoin Retrace From Pre-Inauguration Highs As Trump Skips Crypto Mention: Analyst Highlights BTC Consolidation In $101K-$106K Range</a>
Why It Matters: The speech&#8217;s omission of digital assets triggered a broader <a href="https://www.benzinga.com/25/01/43088563/bitcoin-vs-gold-peter-schiff-decodes-trumps-golden-age-reference-in-inaugural-speech">crypto market decline</a>, with Bitcoin falling from $106,000 to $101,775.
The selloff comes as Trump named Mark Uyeda as acting U.S. Securities and Exchange Commission chair, replacing Gary Gensler. 
The firm has been purchasing Bitcoin for ten consecutive weeks, according to its public disclosures.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43088840/donald-and-melania-trump-memecoins-crash-after-presidential-inaugurationfirst-couples-crypto-wealth-plunges-36">Donald And Melania Trump Memecoins Crash, Erode Billions In Investors&#8217; Wealth</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Equities

$BTC

MSTR

MicroStrategy Drops Nearly 4% In Tuesday Premarket After Trump's Inauguration Speech Sidelines Cryptocurrency, Bitcoin Retreats Below $102K (UPDATED)

Keefe, Bruyette &amp; Woods analyst Wood Lay initiates coverage on Firstsun Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSUN#NASDAQ">FSUN</a>) with a Outperform rating and announces Price Target of $46.

Initiation

FSUN

Keefe, Bruyette & Woods Initiates Coverage On Firstsun Capital with Outperform Rating, Announces Price Target of $46

Highlights and Key Items:
<ul>
<li>Recorded full year 2024 sales volumes of 24,100 to 24,600 working interest ("WI") barrels of oil equivalent per day ("BOEPD"), at the midpoint of its guidance range of 23,500 to 25,100 WI BOEPD;
<ul>
<li>Full year 2024 sales volumes were 19,400 to 19,800 net revenue interest ("NRI") BOEPD, at the midpoint of the Company's guidance range of 18,800 to 20,300 NRI BOEPD;</li>
</ul>
</li>
<li>Generated Q4 2024 sales volumes of about 23,600 to 24,000 WI BOEPD, or 19,100 to 19,500 NRI BOEPD, both within guidance;</li>
<li>Produced between 24,550 and 25,050 WI BOEPD for full year 2024, in line with the midpoint of its full year guidance range of 24,100 to 25,400 WI BOEPD;
<ul>
<li>Full year 2024 production volumes were 19,800 to 20,200 NRI BOEPD, above the midpoint of the Company's guidance range of 19,300 to 20,600 NRI BOEPD; and</li>
</ul>
</li>
<li>Delivered Q4 2024 production of about 25,100 to 25,600 WI BOEPD, or 20,600 to 21,000 NRI BOEPD, in line with guidance.</li>
</ul>

VAALCO Energy Reports Record 2024 Sales Volumes Of 24,100-24,600 BOEPD, Exceeding Guidance Midpoints

New Oriental Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) reported quarterly adjusted earnings of $0.22 per share which missed the analyst consensus estimate of $0.30 by 26.67 percent. This is a 24.14 percent decrease over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $1.04 billion which beat the analyst consensus estimate of $1.03 billion by 0.78 percent. This is a 19.37 percent increase over sales of $869.60 million the same period last year.

Earnings Misses

New Oriental Education Q2 Adj $0.22 Misses $0.30 Estimate, Sales $1.04B Beat $1.03B Estimate

The company will host a conference call to discuss feedback received from its Type C meeting on bitopertin in EPP with the U.S. Food and Drug Administration (FDA). The conference call will be held on Tuesday, January 21, at 8:00 am EST

IRON

Reported Monday, Disc Medicine Announces Conference Call To Review FDA Feedback On Bitopertin For EPP

Ontrak, Inc. (OTRK) Q2 2024 Earnings Call Transcript

Ontrak to conduct 1-for-15 reverse stock split

Ontrak ( ($OTRK) ) has issued an update. Ontrak, Inc. has announced a 1-for-15 reverse stock split, slated to be effective at the start of trading ...

Ontrak Implements Reverse Split to Satisfy Nasdaq Requirements

These are the upcoming stock splits for the week of September 23 to September 27, based on&nbsp;TipRanks' Stock Splits Calendar. A stock split is a...

Upcoming Stock Splits This Week (September 23 to September 27) – Stay Invested

Ontrak Q3 Earnings Preview

Here are the major earnings after the close today

Ontrak Non-GAAP EPS of -$1.38, revenue of $2.6M in-line

Reports Q3 revenue $2.569M vs $3.715M last year. Brandon LaVerne, Ontrak (OTRK) Health's Chief Executive Officer, stated, "I am thrilled that we ha...

Ontrak reports Q3 EPS ($1.38) vs ($24.15) last year

Ontrak, Inc. (OTRK) Q3 2024 Earnings Call Transcript

Ontrak, Inc. ( ($OTRK) ) has released its Q3 earnings. Here is a breakdown of the information Ontrak, Inc. presented to its investors. Ontrak, Inc....

Ontrak, Inc. Reports Q3 Earnings and Strategic Initiatives

ADAP

AEMD

AGRO

AOIFF

AYTU

BDORY

BNGO

BOXL

BRFS

CAPR

CSCO

DADA

DGII

DRRX

ECOR

EVTL

GLAD

GRYP

HROW

KLIC

MPLN

NLCP

OMER

OTRKP

PVCT

RSLS

SMSI

SONO

SPRU

TLPH

TRAW

TTEK

VXRT

Press Releases

Ontrak Health Launches Innovative Solution to Improve Quality Measures and Boost Performance Scores

Ontrak Health to Present at National Healthcare Industry Events

Ontrak Health Demonstrates Significant Improvement in Members' Quality of Life from ReQoL Mental Health Assessment

Ontrak, Inc. Announces Reverse Stock Split

"Peraso Inc. (NASDAQ: PSRO) Pioneers mmWave Technology: The Next-Generation Wireless Communications" see bonus stocks inside…..

Ontrak Health Collaborates with Major Northeast Regional Plan to Bridge HEDIS Care Gaps Using Ontrak Quality Solution

Ontrak Health to Report 2024 Third Quarter Financial Results on November 13, 2024

Ontrak Health Expands Behavioral Health Solutions with Sentara Health Plans for Commercial and Marketplace Populations

Ontrak Health Announces 2024 Third Quarter Financial Results

Ontrak Health Announces New Customer Partnership with Intermountain Health to Deliver Value-Based Behavioral Health Services to Medicare Advantage Members

BPTH

LASE

PSRO

American Shared Hospital Services Common Stock

American Shared Hospital

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

23andMe Holding

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

Precipio

SHL Telemedicine Ltd - American Depositary Shares

SHL Telemedicine

Syra Health

Vivos Therapeutics

Roth MKM

Canaccord Genuity

RBC Capital

Comments

Ontrak

Ontrak (OTRK) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌